DDN Rolls Out Comprehensive Rebranding Campaign.

New service offerings, website, logo reflect DDN commitment to 'Propelling Life Science'

MENOMONEE FALLS, Wis. -- DDN Pharmaceutical Logistics, a single-source provider of innovative supply-chain solutions and third-party logistics for pharmaceutical clients, today announced a comprehensive rebranding campaign that centers on highlighting DDN's expertise in launching and supporting pharmaceutical products through commercialization.

At an event taking place today in Menomonee Falls, DDN employees are getting a first look at the comprehensive effort, which is being supported with a new, user-friendly website (www.ddnnet.com), an industry advertising campaign and an expanded roster of service offerings, which will be formally announced in the coming months.

In particular, the website will provide a trove of information, including sections for case studies and a 'Knowledge Center' that will offer an array of up-to-the-minute data about industry trends and innovative thinking that utilizes the breadth and depth of DDN's experts.

"As the life science industry evolves, we saw the need to emphasize our unique position in the marketplace, stressing our expertise, and the quality and value of our customized services," DDN President Ross Bjella said. "That is why our credo, 'Propelling Life Science,' is so fitting. DDN has a great story to tell, with many successes in helping life science companies commercialize their products. This campaign is one way to give our partners, our employees and the world at large a clear sense of what DDN is doing and where we are heading."

DDN's service offering ensures a streamlined process of getting safe, and more affordable pharmaceutical products in patients' hands to help improve their quality of life. DDN forms partnerships at all levels, from biologic startups to providing support services for established manufacturers. Beyond warehousing and distribution, DDN's other services include processing Medicaid claims, coordinating client chargebacks, administering customer call centers, and other contract management services.

DDN has enjoyed consistently strong growth:

* Growth has averaged over 20-percent year over year for the past three years, with total revenue more than doubling since 2006.

* In 2006, DDN handled just over 35 million units of medicine. In 2008, that number is expected to reach 100 million units.

* Since the end of 2006, DDN has nearly doubled the size of its client list, from 45 to 80 clients, with a goal of adding at least 5 more clients by the end of 2008.

* DDN's rapid rise has occurred at the same time DDN has maintained inventory and shipping accuracy of better than 99.9-percent, which is far in excess of industry standards.

Noting that DDN's parent company, the F. Dohmen Company, is celebrating its 150th anniversary this fall, Bjella said the time is right to undergo a brand transition to correspond with DDN's expanded vision and growing business.

"Our business has changed significantly over the last few years and the new branding supports our expanded services to life science companies. This doesn't represent a change in direction for DDN as much as it reflects DDN's aggressive and targeted plan for growth in a small but highly competitive marketplace," Bjella said. "Our efforts are already bearing fruit, and we realized it was time to share our sense of excitement over the role DDN will continue to play in bringing life science products to market and supporting their growth every step of the way."